Kedar Hastak

1.7k total citations
12 papers, 1.4k citations indexed

About

Kedar Hastak is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kedar Hastak has authored 12 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kedar Hastak's work include Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (4 papers) and Tea Polyphenols and Effects (4 papers). Kedar Hastak is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (4 papers) and Tea Polyphenols and Effects (4 papers). Kedar Hastak collaborates with scholars based in United States, Australia and India. Kedar Hastak's co-authors include Hasan Mukhtar, Nihal Ahmad, Sanjay Gupta, Mukesh K. Agarwal, Munna L. Agarwal, Jonathan Lewin, James M. Ford, Elizabeth Alli, Farrukh Afaq and Mark W. Jackson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Kedar Hastak

12 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kedar Hastak United States 11 584 528 360 287 251 12 1.4k
Jie Liao United States 23 331 0.6× 635 1.2× 206 0.6× 167 0.6× 99 0.4× 37 1.6k
Rafal Swiercz United States 14 465 0.8× 575 1.1× 184 0.5× 245 0.9× 85 0.3× 16 1.3k
Hiroki Makita Japan 21 188 0.3× 679 1.3× 345 1.0× 234 0.8× 36 0.1× 47 1.5k
Subapriya Rajamanickam United States 17 116 0.2× 805 1.5× 165 0.5× 110 0.4× 105 0.4× 24 1.3k
Nipin Sp South Korea 19 131 0.2× 587 1.1× 202 0.6× 111 0.4× 76 0.3× 41 1.2k
Achinto Saha United States 20 136 0.2× 731 1.4× 273 0.8× 124 0.4× 46 0.2× 43 1.7k
Alpna Tyagi United States 22 114 0.2× 783 1.5× 235 0.7× 146 0.5× 83 0.3× 31 1.4k
Stephanie J. Muga United States 17 150 0.3× 605 1.1× 177 0.5× 120 0.4× 34 0.1× 26 1.4k
Mary F. Krutzsch United States 9 243 0.4× 281 0.5× 273 0.8× 109 0.4× 50 0.2× 11 1.0k
Yuhui Huang Japan 16 365 0.6× 356 0.7× 112 0.3× 131 0.5× 73 0.3× 36 884

Countries citing papers authored by Kedar Hastak

Since Specialization
Citations

This map shows the geographic impact of Kedar Hastak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedar Hastak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedar Hastak more than expected).

Fields of papers citing papers by Kedar Hastak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedar Hastak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedar Hastak. The network helps show where Kedar Hastak may publish in the future.

Co-authorship network of co-authors of Kedar Hastak

This figure shows the co-authorship network connecting the top 25 collaborators of Kedar Hastak. A scholar is included among the top collaborators of Kedar Hastak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedar Hastak. Kedar Hastak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hastak, Kedar, et al.. (2017). Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers. Oncotarget. 8(16). 26344–26355. 13 indexed citations
2.
Hastak, Kedar, Shanthi Adimoolam, Nathan D. Trinklein, R Myers, & James M. Ford. (2012). Identification of a Functional In Vivo p53 Response Element in the Coding Sequence of the Xeroderma Pigmentosum Group C Gene. Genes & Cancer. 3(2). 131–140. 12 indexed citations
3.
Hastak, Kedar, Elizabeth Alli, & James M. Ford. (2010). Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin. Cancer Research. 70(20). 7970–7980. 127 indexed citations
4.
Thakur, Vijay S., A.R.M. Ruhul Amin, Rajib Paul, et al.. (2010). p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Letters. 296(2). 225–232. 46 indexed citations
5.
Hastak, Kedar, Rajib Paul, Mukesh K. Agarwal, et al.. (2008). DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation. Proceedings of the National Academy of Sciences. 105(17). 6314–6319. 55 indexed citations
6.
Hastak, Kedar, Elizabeth Alli, & James M. Ford. (2007). Novel treatment options for triple-negative breast cancers. Molecular Cancer Therapeutics. 6. 1 indexed citations
7.
Agarwal, Mukesh K., Kedar Hastak, Mark W. Jackson, et al.. (2006). Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors. Proceedings of the National Academy of Sciences. 103(44). 16278–16283. 53 indexed citations
8.
Hastak, Kedar, Mukesh K. Agarwal, Hasan Mukhtar, & Munna L. Agarwal. (2005). Ablation of either p21 or Bax prevents p53‐dependent apoptosis induced by green tea polyphenol epigallocatechin‐3‐gallate. The FASEB Journal. 19(7). 1–19. 135 indexed citations
9.
Hastak, Kedar, Sanjay Gupta, Nihal Ahmad, et al.. (2003). Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 22(31). 4851–4859. 266 indexed citations
10.
Gupta, Sanjay, Kedar Hastak, Farrukh Afaq, Nihal Ahmad, & Hasan Mukhtar. (2003). Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis. Oncogene. 23(14). 2507–2522. 180 indexed citations
11.
Gupta, Sanjay, Kedar Hastak, Nihal Ahmad, Jonathan Lewin, & Hasan Mukhtar. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proceedings of the National Academy of Sciences. 98(18). 10350–10355. 391 indexed citations
12.
Hastak, Kedar, et al.. (1997). Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Letters. 116(2). 265–269. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Liao Breakdown of academic impact, for papers by Rafal Swiercz Breakdown of academic impact, for papers by Hiroki Makita Breakdown of academic impact, for papers by Subapriya Rajamanickam Breakdown of academic impact, for papers by Nipin Sp Breakdown of academic impact, for papers by Achinto Saha Breakdown of academic impact, for papers by Alpna Tyagi Breakdown of academic impact, for papers by Stephanie J. Muga Breakdown of academic impact, for papers by Mary F. Krutzsch Breakdown of academic impact, for papers by Yuhui Huang
Rankless by CCL
2026